Clinical Trial Update: Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis [Phase 4]

View source ↗

Summary

A Phase 4 post-marketing study evaluating the efficacy and safety of micafungin for invasive aspergillosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• Micafungin (micafungin)

Snippet

Sponsor: Astellas Pharma China, Inc. | Conditions: Invasive Aspergillosis | Phase 4 | Status: TERMINATED